Texas Movement Disorder Specialists | Georgetown, TX

Research site

Location

204 South Interstate-35, Suite 103, Georgetown, Texas, United States of America

Site insights

Top conditions

Top treatments

ABBV-951

Carbidopa

Levodopa

CVN424

BOTOX

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Michael Soileau

Verified by this site

Active trials

4 of 14 total trials

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered...

Enrolling

Parkinson Disease

Drug: AAV2-GDNF gene therapy

Procedure: control surgery

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (P...

Enrolling

Parkinson Disease

Drug: CREXONT ER

Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation (ROAM-DBS)

The purpose of the ROAM-DBS study is to compare the time needed to achieve a 1 point improvement Patient's Global Impression of change (PGIC) relativ...

Active, not recruiting

Parkinson Disease

Device: Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature (virtual clinic and in-clinic sessions)

Device: Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Part...

Active, not recruiting

Parkinson Disease

Drug: Placebo

Drug: CVN424 75 mg